OVARIAN CARCINOMA
Clinical trials for OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to halt ovarian cancer recurrence detected in blood
Disease control Not yet recruitingThis phase II trial tests whether an IGFBP-2 vaccine, given after one dose of carboplatin, can stop ovarian cancer from growing in patients whose recurrence is detected only through a blood test. The vaccine helps the immune system target cancer cells, while carboplatin primes th…
Matched conditions: OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New antibody drug aims to turn immune cells against cancer
Disease control Not yet recruitingThis early-stage study tests a new drug called NPX372 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to help the body's immune cells recognize and attack cancer cells. The main goals are to check the drug's safety and fin…
Matched conditions: OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: NextPoint Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New study explores combining cancer and blood vessel surgery for advanced gynecologic tumors
Knowledge-focused Not yet recruitingThis study looks at how well patients do after surgery that removes both advanced gynecologic cancers and the major blood vessels they have grown into. Researchers will track 130 participants for up to 5 years to see survival rates and how long it takes for the cancer to return. …
Matched conditions: OVARIAN CARCINOMA
Sponsor: National Cancer Institute, Naples • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC